Skip to main content

Gilead to buy cancer drugmaker Immunomedics for $21 billion

Gilead to buy cancer drugmaker Immunomedics for $21 billion  image

Gilead to buy cancer drugmaker Immunomedics for $21 billion - Yahoo Finance

The deal provides Gilead access to Immunomedics' breast cancer treatment drug, Trodelvy, which was granted an accelerated FDA approval in April. Gilead said it would issue a tender offer to buy all the outstanding shares of Immunomedics for $88 per share, re…
Read More

In Similar Category

From Yahoo Entertainment